Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 8-K Event Material agreement · Unregistered share sale
  2. S-1/A Offering Registration Statement
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. 10-K Report Annual Report
  5. CT ORDER Other Confidential Order
  6. 8-K Event Regulation FD disclosure
  7. SC 13D/A Stake Beneficial Ownership Report
  8. SC 13D/A Stake Beneficial Ownership Report
  9. SC 13D/A Stake Beneficial Ownership Report
  10. SC 13D/A Stake Beneficial Ownership Report
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 8-K Event Material agreement
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. UPLOAD Other SEC-generated Letter
  16. 10-Q Report Quarterly Report
  17. S-1 Offering Registration Statement
  18. 8-K Event Results of operations
  19. 10-Q Report Quarterly Report
  20. 4 Insider Changes in Ownership

Page 37 of 72 · 1,429 filings